Biotage AB (publ) (BIOT.ST)
SEK 158.8
(1.73%)
SEK 158.8
(1.73%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 246 Million SEK | -8.21% |
| 2022 | 268 Million SEK | 30.73% |
| 2021 | 205 Million SEK | 17.14% |
| 2020 | 175 Million SEK | -6.33% |
| 2019 | 186.82 Million SEK | 11.45% |
| 2018 | 167.62 Million SEK | 20.81% |
| 2017 | 138.74 Million SEK | 49.52% |
| 2016 | 92.79 Million SEK | 26.68% |
| 2015 | 73.25 Million SEK | 43.32% |
| 2014 | 51.11 Million SEK | 23.48% |
| 2013 | 41.39 Million SEK | 7.97% |
| 2012 | 38.33 Million SEK | 18.05% |
| 2011 | 32.47 Million SEK | 107.92% |
| 2010 | -410.24 Million SEK | -3143.8% |
| 2009 | 13.47 Million SEK | -95.49% |
| 2008 | 299.05 Million SEK | 200.94% |
| 2007 | 99.37 Million SEK | 3428.87% |
| 2006 | 2.81 Million SEK | 107.06% |
| 2005 | -39.89 Million SEK | 65.32% |
| 2004 | -115.02 Million SEK | 52.94% |
| 2003 | -244.39 Million SEK | -45.15% |
| 2002 | -168.37 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 45 Million SEK | -6.25% |
| 2024 Q2 | 48 Million SEK | 45.45% |
| 2024 Q1 | 33 Million SEK | -74.81% |
| 2023 Q1 | 43 Million SEK | -41.89% |
| 2023 FY | 246 Million SEK | -8.21% |
| 2023 Q3 | 38 Million SEK | 11.76% |
| 2023 Q2 | 34 Million SEK | -20.93% |
| 2023 Q4 | 131 Million SEK | 244.74% |
| 2022 Q3 | 65 Million SEK | 14.04% |
| 2022 FY | 268 Million SEK | 30.73% |
| 2022 Q1 | 71 Million SEK | 54.35% |
| 2022 Q2 | 57 Million SEK | -19.72% |
| 2022 Q4 | 74 Million SEK | 13.85% |
| 2021 FY | 205 Million SEK | 17.14% |
| 2021 Q1 | 60.04 Million SEK | 35.21% |
| 2021 Q2 | 45.97 Million SEK | -23.43% |
| 2021 Q4 | 46 Million SEK | -13.21% |
| 2021 Q3 | 53 Million SEK | 15.29% |
| 2020 Q1 | 61.34 Million SEK | 231.73% |
| 2020 FY | 175 Million SEK | -6.33% |
| 2020 Q4 | 44.4 Million SEK | 18.87% |
| 2020 Q3 | 37.35 Million SEK | 15.93% |
| 2020 Q2 | 32.22 Million SEK | -47.47% |
| 2019 FY | 186.82 Million SEK | 11.45% |
| 2019 Q3 | 66.63 Million SEK | 22.99% |
| 2019 Q2 | 54.17 Million SEK | 14.02% |
| 2019 Q1 | 47.51 Million SEK | 73.88% |
| 2019 Q4 | 18.49 Million SEK | -72.25% |
| 2018 Q1 | 44.85 Million SEK | 29.45% |
| 2018 FY | 167.62 Million SEK | 20.81% |
| 2018 Q2 | 51.41 Million SEK | 14.64% |
| 2018 Q3 | 44.02 Million SEK | -14.38% |
| 2018 Q4 | 27.32 Million SEK | -37.93% |
| 2017 Q3 | 31.12 Million SEK | -17.38% |
| 2017 Q1 | 35.29 Million SEK | 101.77% |
| 2017 Q2 | 37.67 Million SEK | 6.75% |
| 2017 FY | 138.74 Million SEK | 49.52% |
| 2017 Q4 | 34.65 Million SEK | 11.32% |
| 2016 Q4 | 17.49 Million SEK | -36.85% |
| 2016 FY | 92.79 Million SEK | 26.68% |
| 2016 Q2 | 24.73 Million SEK | 8.12% |
| 2016 Q1 | 22.87 Million SEK | 10.39% |
| 2016 Q3 | 27.7 Million SEK | 12.01% |
| 2015 FY | 73.25 Million SEK | 43.32% |
| 2015 Q4 | 20.72 Million SEK | 13.39% |
| 2015 Q3 | 18.27 Million SEK | 16.7% |
| 2015 Q2 | 15.65 Million SEK | -15.84% |
| 2015 Q1 | 18.6 Million SEK | 11.71% |
| 2014 FY | 51.11 Million SEK | 23.48% |
| 2014 Q2 | 15.39 Million SEK | 90.85% |
| 2014 Q3 | 10.99 Million SEK | -28.56% |
| 2014 Q1 | 8.06 Million SEK | -56.37% |
| 2014 Q4 | 16.65 Million SEK | 51.43% |
| 2013 Q3 | 6.91 Million SEK | -46.4% |
| 2013 FY | 41.39 Million SEK | 7.97% |
| 2013 Q1 | 3.07 Million SEK | -77.39% |
| 2013 Q2 | 12.9 Million SEK | 319.23% |
| 2013 Q4 | 18.48 Million SEK | 167.18% |
| 2012 Q4 | 13.61 Million SEK | 271.16% |
| 2012 Q3 | 3.66 Million SEK | -72.18% |
| 2012 Q1 | 7.86 Million SEK | -54.19% |
| 2012 Q2 | 13.18 Million SEK | 67.71% |
| 2012 FY | 38.33 Million SEK | 18.05% |
| 2011 FY | 32.47 Million SEK | 107.92% |
| 2011 Q2 | 2.38 Million SEK | 59.84% |
| 2011 Q3 | 11.44 Million SEK | 380.8% |
| 2011 Q4 | 17.16 Million SEK | 49.99% |
| 2011 Q1 | 1.48 Million SEK | 100.35% |
| 2010 Q3 | 4.68 Million SEK | -29.38% |
| 2010 Q2 | 6.63 Million SEK | 106.48% |
| 2010 Q1 | 3.21 Million SEK | -88.56% |
| 2010 FY | -410.24 Million SEK | -3143.8% |
| 2010 Q4 | -424.76 Million SEK | -9172.32% |
| 2009 Q2 | 5.48 Million SEK | 125.73% |
| 2009 Q4 | 28.06 Million SEK | 2177.92% |
| 2009 Q1 | -21.29 Million SEK | 0.0% |
| 2009 FY | 13.47 Million SEK | -95.49% |
| 2009 Q3 | 1.23 Million SEK | -77.52% |
| 2008 FY | 299.05 Million SEK | 200.94% |
| 2007 FY | 99.37 Million SEK | 3428.87% |
| 2006 FY | 2.81 Million SEK | 107.06% |
| 2005 FY | -39.89 Million SEK | 65.32% |
| 2004 FY | -115.02 Million SEK | 52.94% |
| 2003 FY | -244.39 Million SEK | -45.15% |
| 2002 FY | -168.37 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AddLife AB (publ) | 190 Million SEK | -29.474% |
| Bonesupport Holding AB (publ) | 245.02 Million SEK | -0.4% |
| Doxa AB (publ) | 291.9 Million SEK | 15.725% |
| Elekta AB (publ) | 1.3 Billion SEK | 81.106% |
| iZafe Group AB (publ) | -32.17 Million SEK | 864.569% |
| Ortivus AB (publ) | -18.24 Million SEK | 1448.315% |
| Ortivus AB (publ) | -18.24 Million SEK | 1448.315% |
| Q-linea AB (publ) | -229.36 Million SEK | 207.252% |
| S2Medical AB (publ) | -22.7 Million SEK | 1183.345% |
| Synsam AB (publ) | 311 Million SEK | 20.9% |